Created in 2001 (United States), HEPSERA own
32 sister brands
and 17477 competing brands.
HEPSERA is owned by Gilead Sciences, listed on the stock exchange of New York
The sector of HEPSERA is Drug Manufacturers.
Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.